CODX logo

Co-Diagnostics (CODX) Company Overview

Profile

Full Name:

Co-Diagnostics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

July 12, 2017

Indexes:

Not included

Description:

Co-Diagnostics, Inc. (CODX) is a biotechnology company that develops and manufactures diagnostic tests for infectious diseases. Their innovative technology focuses on molecular testing, helping healthcare providers detect diseases quickly and accurately, improving patient outcomes and public health responses.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 11, 24 HC Wainwright & Co.
Neutral
Aug 12, 24 HC Wainwright & Co.
Neutral
Jun 17, 24 HC Wainwright & Co.
Neutral
May 13, 24 HC Wainwright & Co.
Neutral
Mar 15, 24 HC Wainwright & Co.
Neutral
Dec 29, 23 HC Wainwright & Co.
Neutral
Nov 13, 23 HC Wainwright & Co.
Neutral
Aug 14, 23 HC Wainwright & Co.
Neutral
May 15, 23 HC Wainwright & Co.
Neutral
Mar 20, 23 HC Wainwright & Co.
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Co-Diagnostics?
  • Does Co-Diagnostics pay dividends?
  • What sector is Co-Diagnostics in?
  • What industry is Co-Diagnostics in?
  • What country is Co-Diagnostics based in?
  • When did Co-Diagnostics go public?
  • Is Co-Diagnostics in the S&P 500?
  • Is Co-Diagnostics in the NASDAQ 100?
  • Is Co-Diagnostics in the Dow Jones?
  • When was Co-Diagnostics's last earnings report?
  • When does Co-Diagnostics report earnings?
  • Should I buy Co-Diagnostics stock now?

What is the ticker symbol for Co-Diagnostics?

The ticker symbol for Co-Diagnostics is NASDAQ:CODX

Does Co-Diagnostics pay dividends?

No, Co-Diagnostics does not pay dividends

What sector is Co-Diagnostics in?

Co-Diagnostics is in the Healthcare sector

What industry is Co-Diagnostics in?

Co-Diagnostics is in the Medical Devices industry

What country is Co-Diagnostics based in?

Co-Diagnostics is headquartered in United States

When did Co-Diagnostics go public?

Co-Diagnostics's initial public offering (IPO) was on July 12, 2017

Is Co-Diagnostics in the S&P 500?

No, Co-Diagnostics is not included in the S&P 500 index

Is Co-Diagnostics in the NASDAQ 100?

No, Co-Diagnostics is not included in the NASDAQ 100 index

Is Co-Diagnostics in the Dow Jones?

No, Co-Diagnostics is not included in the Dow Jones index

When was Co-Diagnostics's last earnings report?

Co-Diagnostics's most recent earnings report was on Nov 7, 2024

When does Co-Diagnostics report earnings?

The next expected earnings date for Co-Diagnostics is Mar 14, 2025

Should I buy Co-Diagnostics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions